MiRNA: The new frontier in cancer medicine

Future Medicinal Chemistry

Volumn 5, Issue 9, 2013, Pages 983-985

  Ju, Jingfang ^a   Jiang, Jingting ^b   Fesler, Andrew ^a  

^a Stony Brook Medicine   (United States)

^b THE THIRD AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

cancer stem cell; microRNA; resistance; therapeutics

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; LONG UNTRANSLATED RNA; MICRORNA; PIWI INTERACTING RNA; SMALL INTERFERING RNA;

3' UNTRANSLATED REGION; APOPTOSIS; CANCER CHEMOTHERAPY; CANCER STEM CELL; GENE EXPRESSION; GENE THERAPY; ONCOLOGY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; RNA DEGRADATION;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; DRUG RESISTANCE, NEOPLASM; GENE TRANSFER TECHNIQUES; HUMANS; MICRORNAS; MUTATION; NEOPLASMS; NEOPLASTIC STEM CELLS; RNA, UNTRANSLATED;

EID: 84878696881     PISSN: 17568919     EISSN: 17568927     Source Type: Journal    
DOI: 10.4155/fmc.13.74     Document Type: Review

References (20)

1. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75(5), 843-854 (1993).
2. Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75(5), 855-862 (1993).
3. Pillai RS, Bhattacharyya SN, Artus CG, et al. Inhibition of translational initiation by Let-7 microRNA in human cells. Science 309(5740), 1573-1576 (2005).
4. Ruvkun G. Clarifications on miRNA and cancer. Science 311(5757), 36-37 (2006).
5. Dony C, Kessel M, Gruss P. Post-transcriptional control of myc and p53 expression during differentiation of the embryonal carcinoma cell line F9. Nature 317(6038), 636-639 (1985).
6. Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA 99(24), 15524-15529 (2002).
7. Yu F, Yao H, Zhu P, et al. Let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131(6), 1109-1123 (2007).
8. Song B, Wang Y, Xi Y, et al. Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene 28(46), 4065-4074 (2009).
9. Ji Q, Hao X, Meng Y, et al. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer 8, 266 (2008).
10. Zhu DX, Zhu W, Fang C, et al. miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes. Carcinogenesis 33(7), 1294-1301 (2012).
11. Park JK, Kogure T, Nuovo GJ, et al. miR-221 silencing blocks hepatocellular carcinoma and promotes survival. Cancer Res. 71(24), 7608-7616 (2011).
12. Krutzfeldt J, Rajewsky N, Braich R, et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438(7068), 685-689 (2005).
13. Wiggins JF, Ruffino L, Kelnar K, et al. Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res. 70(14), 5923-5930 (2010).
14. Obad S, dos Santos CO, Petri A, et al. Silencing of microRNA families by seed-targeting tiny LNAs. Nat. Genet. 43(4), 371-378 (2011).
15. Kurreck J, Wyszko E, Gillen C, Erdmann VA. Design of antisense oligonucleotides stabilized by locked nucleic acids. Nucleic Acids Res. 30(9), 1911-1918 (2002).
16. Chen C, Akerstrom V, Baus J, Lan MS, Breslin MB. Comparative analysis of the transduction efficiency of five adeno associated virus serotypes and VSV-G pseudotype lentiviral vector in lung cancer cells. Virol. J. 10, 86 (2013).
17. Kota J, Chivukula RR, O'Donnell KA, et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137(6), 1005-1017 (2009).
18. Rai K, Takigawa N, Ito S, et al. Liposomal delivery of microRNA-7-expressing plasmid overcomes epidermal growth factor receptor tyrosine kinase inhibitor-resistance in lung cancer cells. Mol. Cancer Ther. 10(9), 1720-1727 (2011).
19. Chen Y, Zhu X, Zhang X, Liu B, Huang L. Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy. Mol. Ther. 18(9), 1650-1656 (2010).
20. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9(6), 654-659 (2007).